| From OPC to oligodendrocyte: an epigenetic journey A Tiane, M Schepers, B Rombaut, R Hupperts, J Prickaerts, N Hellings, ... Cells 8 (10), 1236, 2019 | 95 | 2019 |
| The molecular biology of phosphodiesterase 4 enzymes as pharmacological targets: an interplay of isoforms, conformational states, and inhibitors D Paes, M Schepers, B Rombaut, D van den Hove, T Vanmierlo, ... Pharmacological Reviews 73 (3), 1016-1049, 2021 | 49 | 2021 |
| Targeting phosphodiesterases—Towards a tailor-made approach in multiple sclerosis treatment M Schepers, A Tiane, D Paes, S Sanchez, B Rombaut, E Piccart, ... Frontiers in Immunology 10, 1727, 2019 | 41 | 2019 |
| DNA methylation regulates the expression of the negative transcriptional regulators ID2 and ID4 during OPC differentiation A Tiane, M Schepers, R Riemens, B Rombaut, P Vandormael, V Somers, ... Cellular and Molecular Life Sciences 78, 6631-6644, 2021 | 30 | 2021 |
| Sphingosine-1-phosphate receptor modulators and oligodendroglial cells: beyond immunomodulation A Roggeri, M Schepers, A Tiane, B Rombaut, L van Veggel, N Hellings, ... International journal of molecular sciences 21 (20), 7537, 2020 | 30 | 2020 |
| Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis M Schepers, D Paes, A Tiane, B Rombaut, E Piccart, L van Veggel, ... Brain, Behavior, and Immunity 109, 1-22, 2023 | 29 | 2023 |
| PDE inhibition in distinct cell types to reclaim the balance of synaptic plasticity B Rombaut, S Kessels, M Schepers, A Tiane, D Paes, Y Solomina, ... Theranostics 11 (5), 2080, 2021 | 19 | 2021 |
| 24 (S)-Saringosterol prevents cognitive decline in a mouse model for Alzheimer’s disease N Martens, M Schepers, N Zhan, F Leijten, G Voortman, A Tiane, ... Marine Drugs 19 (4), 190, 2021 | 18 | 2021 |
| From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions A Tiane, M Schepers, RA Reijnders, L van Veggel, S Chenine, ... Acta neuropathologica 146 (2), 283-299, 2023 | 9 | 2023 |
| Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology D Paes, M Schepers, E Willems, B Rombaut, A Tiane, Y Solomina, ... Cellular and Molecular Life Sciences 80 (7), 178, 2023 | 9 | 2023 |
| Exogenous oxytocin administration restores memory in female APP/PS1 mice P Koulousakis, E Willems, M Schepers, B Rombaut, J Prickaerts, ... Journal of Alzheimer's Disease, 1-19, 2023 | 5 | 2023 |
| From OPC to oligodendrocyte: an epigenetic journey. Cells 8: 1236 A Tiane, M Schepers, B Rombaut, R Hupperts, J Prickaerts, N Hellings, ... | 5 | 2019 |
| EAAT3 modulation of the oligodendrocyte lineage in in vitro and in vivo models of Multiple Sclerosis L VAN VEGGEL, M SCHEPERS, A TIANE, B ROMBAUT, J Royakkers, ... Wiley, 2023 | 1 | 2023 |
| The use of seaweed-derived phytosterols to defeat Alzheimer's Disease N Martens, M Schepers, N Zhan, F Leijten, G Voortman-Minderman, ... Atherosclerosis 355, 6, 2022 | 1 | 2022 |
| Early Inhibition of Phosphodiesterase 4B (PDE4B) Instills Cognitive Resilience in APPswe/PS1dE9 Mice B Rombaut, M Schepers, A Tiane, F Mussen, L Koole, S Kessels, ... Cells 13 (12), 1000, 2024 | | 2024 |
| PDE4B as a key regulator of out of control microglia B ROMBAUT, S KESSELS, C TRIPPAERS, M SCHEPERS, A TIANE, ... WILEY, 2023 | | 2023 |
| Disrupted-In-Schizophrenia 1 controls microglial movement and phagocytosis S KESSELS, K RAMANATHAN, L BERDEN, C TRIPPAERS, J BEEKEN, ... WILEY, 2023 | | 2023 |
| Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis T VANMIERLO, M SCHEPERS, D PAES, A TIANE, B ROMBAUT, ... WILEY, 2023 | | 2023 |
| From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions 2023.01. 12.523740 A Tiane, M Schepers, RA Reijnders, LV Veggel, S Chenine, B Rombaut, ... Cold Spring Harbor Laboratory, 2023 | | 2023 |
| Disrupted-In-Schizophrenia 1 controls microglial movement and phagocytosis S KESSELS, L BERDEN, Y AGUIAR ALPIZAR, J BEEKEN, C TRIPPAERS, ... WILEY, 2021 | | 2021 |
